1 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of the Clearance of Minimal Residual Disease Measured at the End of First-line Treatment in Patients With LymphomaB-cell neoplasm, Hemic and Lymphatic Diseases, Hodgkins lymphoma, Neoplasm, Residual, Neoplasms by Histologic Type, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasmActive, not recruitingNot applicable2025-12-30NCT06744075